Literature DB >> 15014651

The Use of Alosetron to Treat SSRI-Induced Gastrointestinal Symptoms.

Timothy R. Berigan1, Karl N. Zeff.   

Abstract

Entities:  

Year:  2000        PMID： 15014651      PMCID： PMC181129          DOI： 10.4088/pcc.v02n0409

Source DB:  PubMed          Journal:  Prim Care Companion J Clin Psychiatry        ISSN： 1523-5998


× No keyword cloud information.
  2 in total

1.  Efficacy and safety of alosetron in women with irritable bowel syndrome: a randomised, placebo-controlled trial.

Authors:  M Camilleri; A R Northcutt; S Kong; G E Dukes; D McSorley; A W Mangel
Journal:  Lancet       Date:  2000-03-25       Impact factor: 79.321

Review 2.  Pharmacological differences of serotonin reuptake inhibitors and possible clinical relevance.

Authors:  B E Leonard
Journal:  Drugs       Date:  1992       Impact factor: 9.546
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.